Quest, Clinical Genomics Extend Deal for Colorectal Cancer Biomarkers

Under the extension of a 2009 deal, Quest will make payments to Clinical Genomics to develop and validate molecular tests for the early detection of colorectal cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.